2519 results

1.  Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.
Lin L, Lu L, Cao W, Li T.
Emerg Microbes Infect.  2020-12-01.  DOI:10.1080/22221751.2020.1746199

2.  The different clinical characteristics of corona virus disease cases between children and their families in China - the character of children with COVID-19.
Su L, Ma X, Yu H, Zhang Z, Bian P, Han Y, Sun J, Liu Y, Yang C, Geng J, Zhang Z, Gai Z.
Emerg Microbes Infect.  2020-12-01.  DOI:10.1080/22221751.2020.1744483

3.  Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.
Xiong Y, Liu Y, Cao L, Wang D, Guo M, Jiang A, Guo D, Hu W, Yang J, Tang Z, Wu H, Lin Y, Zhang M, Zhang Q, Shi M, Liu Y, Zhou Y, Lan K, Chen Y.
Emerg Microbes Infect.  2020-12-01.  DOI:10.1080/22221751.2020.1747363

4.  Rheumotologitsts' view on the use of hydroxychloroquine to treat COVID-19.
Sun X, Ni Y, Zhang M.
Emerg Microbes Infect.  2020-12-01.  DOI:10.1080/22221751.2020.1760145

5.  Epidemiology and clinical course of COVID-19 in Shanghai, China.
Shen Y, Zheng F, Sun D, Ling Y, Chen J, Li F, Li T, Qian Z, Zhang Y, Xu Q, Liu L, Huang Q, Shan F, Xu L, Wu J, Zhu Z, Song Z, Li S, Shi Y, Zhang J, Wu X, Mendelsohn JB, Zhu T, Lu H.
Emerg Microbes Infect.  2020-12-01.  DOI:10.1080/22221751.2020.1787103

6.  Proposed Modifications in the 6-Minute Walk Test for Potential Application in Patients With Mild COVID-19: A Step to Optimize Triage Guidelines.
Mantha S, Tripuraneni SL, Roizen MF, Fleisher LA.
Anesth Analg.  2020-08-01.  DOI:10.1213/ane.0000000000004986

7.  The spectrum of pathological findings in coronavirus disease (COVID-19) and the pathogenesis of SARS-CoV-2.
Barth RF, Buja LM, Parwani AV.
Diagn Pathol.  2020-07-14.  DOI:10.1186/s13000-020-00999-9

8.  Hematolological Manifestations of COVID-19: From Cytopenia to Coagulopathy.
Agbuduwe C, Basu S.
Eur J Haematol.  2020-07-14.  DOI:10.1111/ejh.13491

9.  Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients.
Cala-García JD, Sierra-Bretón JD, Cavelier-Baiz JE, Faccini-Martínez ÁA, Pérez-Díaz CE.
Immunotherapy.  2020-07-14.  DOI:10.2217/imt-2020-0154

10.  Clinical, radiological and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients.
Zhang JJ, Cao YY, Tan G, Dong X, Wang BC, Lin J, Yan YQ, Liu GH, Akdis M, Akdis CA, Gao YD.
Allergy.  2020-07-14.  DOI:10.1111/all.14496

11.  Accuracy of CT in a cohort of symptomatic patients with suspected COVID-19 pneumonia during the outbreak peak in Italy.
Besutti G, Giorgi Rossi P, Iotti V, Spaggiari L, Bonacini R, Nitrosi A, Ottone M, Bonelli E, Fasano T, Canovi S, Colla R, Massari M, Lattuada IM, Trabucco L, Pattacini P, Reggio Emilia COVID-19 Working Group.
Eur Radiol.  2020-07-14.  DOI:10.1007/s00330-020-07050-x

12.  Relationship of chest CT score with clinical characteristics of 108 patients hospitalized with COVID-19 in Wuhan, China.
Zhang J, Meng G, Li W, Shi B, Dong H, Su Z, Huang Q, Gao P.
Respir Res.  2020-07-14.  DOI:10.1186/s12931-020-01440-x

13.  Neurological manifestations of COVID-19: a systematic review.
Nepal G, Rehrig JH, Shrestha GS, Shing YK, Yadav JK, Ojha R, Pokhrel G, Tu ZL, Huang DY.
Crit Care.  2020-07-13.  DOI:10.1186/s13054-020-03121-z

14.  Immune-mediated approaches against COVID-19.
Florindo HF, Kleiner R, Vaskovich-Koubi D, Acúrcio RC, Carreira B, Yeini E, Tiram G, Liubomirski Y, Satchi-Fainaro R.
Nat Nanotechnol.  2020-07-13.  DOI:10.1038/s41565-020-0732-3

15.  Community-Based Assessment of Knowledge, Attitude, Practices and Risk Factors Regarding COVID-19 Among Pakistanis Residents During a Recent Outbreak: A Cross-Sectional Survey.
Afzal MS, Khan A, Qureshi UUR, Saleem S, Saqib MAN, Shabbir RMK, Naveed M, Jabbar M, Zahoor S, Ahmed H.
J Community Health.  2020-07-13.  DOI:10.1007/s10900-020-00875-z

16.  COVID-19: review of case reports.
Oda Y.
J Anesth.  2020-07-12.  DOI:10.1007/s00540-020-02825-4

17.  QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin.
C Hsia B, Greige N, A Quiroz J, S Khokhar A, Daily J, Di Biase L, J Ferrick K, D Fisher J, Krumerman A.
J Interv Card Electrophysiol.  2020-07-11.  DOI:10.1007/s10840-020-00822-x

18.  Risk factors influencing the prognosis of elderly patients infected with COVID-19: a clinical retrospective study in Wuhan, China.
Gao S, Jiang F, Jin W, Shi Y, Yang L, Xia Y, Jia L, Wang B, Lin H, Cai Y, Xia Z, Peng J.
Aging (Albany NY).  2020-07-11.  DOI:10.18632/aging.103631

19.  Blood cell counts and lymphocyte subsets of patients admitted during the COVID-19 pandemic: a prospective cohort study.
Hengeveld PJ, Omar Khader A, de Bruin LHA, Geelen IGP, van Baalen EA, Jansen E, Bouwer NI, Balak Ö, Riedl JA, Langerak AW, Westerweel PE, Levin MD.
Br J Haematol.  2020-07-11.  DOI:10.1111/bjh.16983

20.  Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes.
Kastritis E, Kitas GD, Vassilopoulos D, Giannopoulos G, Dimopoulos MA, Sfikakis PP.
Rheumatol Int.  2020-07-11.  DOI:10.1007/s00296-020-04629-x